Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oxaallylamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel copper-catalyzed hydroamination method offers high atom economy and mild conditions for scalable pharmaceutical intermediate production.
Patent CN112441934B discloses a mild copper-catalyzed method for halogenated oxaallylamine synthesis, offering reliable supply and cost reduction in API manufacturing.
Novel copper-catalyzed method for halogenated oxaallylamines. Reduces steps, improves yield for beta-blocker intermediates. Ideal for API manufacturing cost reduction.
Patent CN112521289B enables copper-catalyzed synthesis with mild conditions and high atom economy for reliable pharmaceutical intermediate supply chains.